Coston McIsaac & Partners Trims Stock Position in Colgate-Palmolive (NYSE:CL)

Coston McIsaac & Partners lowered its position in shares of Colgate-Palmolive (NYSE:CL) by 13.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,966 shares of the company’s stock after selling 924 shares during the period. Coston McIsaac & Partners’ holdings in Colgate-Palmolive were worth $541,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the company. Algert Global LLC increased its position in shares of Colgate-Palmolive by 14.4% during the second quarter. Algert Global LLC now owns 5,131 shares of the company’s stock valued at $498,000 after acquiring an additional 647 shares during the last quarter. NewEdge Advisors LLC boosted its position in shares of Colgate-Palmolive by 11.7% during the 2nd quarter. NewEdge Advisors LLC now owns 51,375 shares of the company’s stock worth $4,985,000 after purchasing an additional 5,363 shares during the period. B. Riley Wealth Advisors Inc. increased its holdings in Colgate-Palmolive by 7.3% in the 2nd quarter. B. Riley Wealth Advisors Inc. now owns 17,851 shares of the company’s stock valued at $1,732,000 after purchasing an additional 1,212 shares during the last quarter. SPC Financial Inc. purchased a new stake in Colgate-Palmolive in the second quarter valued at approximately $227,000. Finally, 3Chopt Investment Partners LLC purchased a new position in shares of Colgate-Palmolive during the second quarter worth $400,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Piper Sandler cut their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a report on Monday, January 6th. UBS Group cut their price target on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research note on Thursday, January 16th. Barclays dropped their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. TD Cowen reduced their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. Finally, Stifel Nicolaus decreased their price target on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a research report on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $102.00.

Colgate-Palmolive Trading Down 0.2 %

CL opened at $89.65 on Thursday. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 52 week low of $82.68 and a 52 week high of $109.30. The business’s 50 day moving average is $91.67 and its two-hundred day moving average is $97.34. The firm has a market cap of $73.24 billion, a price-to-earnings ratio of 25.69, a price-to-earnings-growth ratio of 3.59 and a beta of 0.44.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.23%. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.31%.

Insider Buying and Selling

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.